STOCK TITAN
  1. Home
  2. Sec-filings
  3. LIVN
  4. [Form 4] LivaNova PLC Insider Trading Activity

LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LivaNova PLC Chief Innovation Officer Ahmet Tezel exercised 12,692 Stock Appreciation Rights at a base price of $52.68 per share, receiving the same number of ordinary shares. In connection with this, 8,589 shares were withheld to pay the SARs base price, 1,428 shares were withheld to satisfy tax liability, and 2,675 shares were sold in open-market transactions at a weighted-average price of $77.7355, within a range of $77.6684–$77.7900. The SARs were granted on June 15, 2024, vest over four years from June 15, 2025, and expire on June 15, 2034.

Positive

  • None.

Negative

  • None.
Insider Tezel Ahmet
Role Chief Innovation Officer
Sold 2,675 shs ($208K)
Approx. gross sale proceeds $208K
Approx. exercise cost $669K
Type Security Shares Price Value
Exercise Stock Appreciation Rights F4 12,692 $0.00 $0.00
Exercise Ordinary Shares 12,692 $52.68 $669K
Disposition Ordinary Shares F1 8,589 $77.86 $669K
Tax Withholding Ordinary Shares F2 1,428 $77.86 $111K
Sale Ordinary Shares F3 2,675 $77.7355 $208K
Holdings After Transaction: Stock Appreciation Rights — 12,691 shares (Direct); Ordinary Shares — 6,090 shares (Direct)
Footnotes (4)
  1. F1. Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs).
  2. F2. Shares withheld to satisfy tax liability.
  3. F3. The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price.
  4. F4. The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement.
SARs exercised 12,692 Stock Appreciation Rights Exercised on 2026-08-11 at a base price of $52.68 per share
SAR base price $52.68 per share Conversion or exercise price of Stock Appreciation Rights exercised
Shares withheld for base price 8,589 shares Shares withheld in payment of the base price upon SAR exercise
Shares withheld for taxes 1,428 shares Shares withheld to satisfy tax liability related to SAR exercise
Shares sold 2,675 shares Ordinary shares sold in open-market transactions on 2026-08-11
Weighted-average sale price $77.7355 per share Weighted-average price for shares sold, within $77.6684–$77.7900 range
Sale price range $77.6684–$77.7900 per share Range of prices for multiple open-market sale transactions
SARs expiration date June 15, 2034 Expiration date of the Stock Appreciation Rights grant
Stock Appreciation Rights financial
"The SARs were granted on June 15, 2024, vesting in four equal annual installments"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
weighted-average sale price financial
"the reported price reflects the weighted-average sale price for the open-market sales"
tax liability financial
"Shares withheld to satisfy tax liability."
Amended and Restated LivaNova PLC 2022 Incentive Award Plan financial
"subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan"

FAQ

What did LivaNova (LIVN) executive Ahmet Tezel report in this Form 4?
Ahmet Tezel reported exercising 12,692 Stock Appreciation Rights at $52.68 per share, receiving ordinary shares, then returning and selling portions of those shares and having some withheld for taxes and exercise price payment.

How many LivaNova (LIVN) shares did Ahmet Tezel sell and at what price?
Ahmet Tezel sold 2,675 ordinary shares in open-market transactions at a weighted-average price of $77.7355 per share, within a disclosed price range from $77.6684 to $77.7900.

How many LivaNova (LIVN) shares were withheld for the SARs base price and taxes?
In connection with the SARs exercise, 8,589 shares were withheld to pay the SARs base price and an additional 1,428 shares were withheld to satisfy the related tax liability, according to the footnotes.

What were the terms of the Stock Appreciation Rights exercised by LivaNova (LIVN) executive Ahmet Tezel?
The Stock Appreciation Rights were granted on June 15, 2024, with a base price of $52.68 per share, vesting in four equal annual installments beginning June 15, 2025, and expiring on June 15, 2034.

Were the LivaNova (LIVN) Form 4 transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan, and the footnotes do not state that the reported transactions were executed pursuant to a Rule 10b5-1 trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tezel Ahmet
(Last)(First)(Middle)
5220 VALIANT COURT
C/O LIVANOVA PLC
(Street)
GLOUCESTERGL3 4FE
(City)(State)(Zip)
UNITED KINGDOM
(Country)		2. Issuer Name and Ticker or Trading Symbol
LivaNova PLC [ LIVN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Innovation Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/11/2026M12,692A$52.6818,782D
Ordinary Shares08/11/2026D8,589D$77.86(1)10,193D
Ordinary Shares08/11/2026F1,428D$77.86(2)8,765D
Ordinary Shares08/11/2026S2,675D$77.7355(3)6,090D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Appreciation Rights$52.6808/11/2026M12,692 (4)06/15/2034Ordinary Shares12,692$012,691D
Explanation of Responses:
1. Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs).
2. Shares withheld to satisfy tax liability.
3. The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price.
4. The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement.
Remarks:
/s/ Sarah K. Mohr, Attorney-in-Fact08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR